MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2024 International Congress

    Early Dementia with Lewy Bodies and Parkinson’s Disease with RBD: two faces of the same coin?

    B. Orso, P. Mattioli, F. Famà, F. Massa, M. Pardini, A. Brugnolo, N. Girtler, S. Raffa, L. Sofia, S. Morbelli, D. Arnaldi (Genoa, Italy)

    Objective: To describe clinical and imaging differences in de novo PD with and without REM sleep Behaviour Disorder (dnPDRBD – de novo PD) and de…
  • 2024 International Congress

    Investigating the Use of 18F-DOPA PET/CT to Improve Diagnosis and Clinical Management of Parkinson’s Disease in South Australian Movement Disorder Clinics.

    D. Sharma, M. Nottage, W. Vallat, R. Wilcox, M. Tan, N. Liam, A. Dwyer (Adelaide, Australia)

    Objective: Evaluate the impact of 18F-DOPA PET/CT on clinical management for Parkinsonism. Background: Parkinson’s Disease affects >100,000 people in Australia with an economic burden of…
  • 2024 International Congress

    Brainstem Monoaminergic Degeneration, Cognition, and Autonomic Symptom Progression in Early Parkinson’s Disease

    KA. Woo, SY. Kim, HY. Choi, JH. Shin, HJ. Kim (Seoul, Republic of Korea)

    Objective: In this study, we aimed to investigate the association between brainstem monoaminergic nuclear degeneration, particularly the serotonergic raphe and noradrenergic locus coeruleus, and cognitive…
  • 2024 International Congress

    Cerebral metabolic network in PLA2G6-associated parkinsonism

    XY. Zhou, J. Wang, C. Chen, FT. Liu, CT. Zuo, JJ. Wu, YM. Sun, J. Wang (Shanghai, China)

    Objective: To characterize the cerebral metabolic network in PLA2G6-associated parkinsonism (PLA2G6-P). Background: PLA2G6-associated neurodegeneration is known as a continuum of phenotypes. Patients with late-onset PLA2G6-associated…
  • 2024 International Congress

    Bistriatal hypermetabolism on 18-FDG PET-CT in tardive dyskinesia

    C. Héraud, C. Alecu, C. Giordana (NICE, France)

    Objective: Tardive dyskinesia (TD) describes various movement disorders developing after treatment with dopamine receptor blocking agents (DRBA), including stereotypy, akathisia, dystonia, tremor, tics and chorea.…
  • 2024 International Congress

    [18F]PR04.MZ PET CT as a clinical tool in the differential diagnosis of PD and other atypical parkinsonian syndromes in the first 5 years of symptoms

    C. Montalva, M. Sanchez, J. Fuentes, P. Chana, P. Salles, V. Kramer, X. Pizarro (Santiago, Chile)

    Objective: Investigate if the [18F]PR04.MZ PET CT is a useful tool in the differential diagnosis of PD and atypical parkinsonian syndromes (AP), mainly MSA and…
  • 2024 International Congress

    A Visual Interpretation Algorithm for Assessing 18F-Florzolotau PET Scans in Progressive Supranuclear Palsy

    F. Liu, J. Wang, C. Zuo (Shanghai, China)

    Objective: This study aimed to develop a visual reading algorithm dedicated to the evaluation of 18F-Florzolotau positron emission tomography (PET) scans in PSP. Background: The…
  • 2024 International Congress

    Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study

    MA. Ruiz Yanzi, M. Matarazzo, JA. Pineda-Pardo, T. Jiménez-Castellanos, MHG. Monje, A. Sánchez-Ferro, R. Martínez-Fernández, C. Gasca-Salas, JA. Obeso (Madrid, Spain)

    Objective: To evaluate the progression of posterior putamen dopaminergic denervation in relation to motor progression in the less affected and more affected side of the…
  • 2024 International Congress

    Key neural tracts involved in tau depositions and neurodegeneration as revealed by multimodal MRI and PET assays in progressive supranuclear palsy

    R. Goto, H. Endo, K. Tagai, Y. Kataoka, K. Hirata, K. Matsuoka, N. Kokubo, M. Oya, H. Matsumoto, S. Kurose, M. Ichihashi, C. Seki, S. Kitamura, S. Moriguchi, K. Takahata, T. Tokuda, Y. Takado, H. Shinotoh, H. Shimada, K. Kawamura, M-R. Zhang, T. Toda, M. Higuchi (Chiba-shi, Japan)

    Objective: Our study aimed to elucidate the impact of tau depositions on brain microstructure and macrostructure in progressive supranuclear palsy (PSP). Background: The link between…
  • 2024 International Congress

    Serotonergic dysfunction and impulse control disorders in Parkinson’s disease: a double-tracer PET study

    S. Prange, E. Metereau, H. Klinger, M. Hudlestone, N. Costes, S. Lancelot, S. Thobois (Bron, France)

    Objective: To investigate the dysfunction of the serotonergic system related to impulse control disorders in patients with Parkinson’s disease. Background: Impulse control disorders (ICDs, including…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley